tregalizumab   

GtoPdb Ligand ID: 9864

Synonyms: BT-061 | hB-F5
Compound class: Antibody
Comment: Tregalizumab (BT-061) is an anti-CD4 monoclonal antibody that was developed by Biotest Ag as a potential anti-rheumatoid arthritis therapy [4].
No information available.
Summary of Clinical Use
Phase 2 clinical trial (NCT01999192) in patients with active RA and an inadequate response to methotrexate, was terminated early as the therapy failed to show clinical efficacy above methotrexate control [3].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01999192 Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis Phase 2 Interventional Biotest